A newly discovered mechanism within blood vessels could hold the key to treating a range of serious conditions, from sepsis to stroke. Researchers at the University of California San Diego have identified how a single protein, called protease-activated receptor-1 (PAR1), can trigger both inflammation and a protective response, a previously puzzling duality. Understanding this process offers a potential pathway to developing therapies that harness the beneficial effects of PAR1 while avoiding harmful inflammation.
PAR1, found on the surface of cells lining blood vessels, plays a critical role in maintaining vascular integrity. Its ability to initiate opposing responses – one that promotes healing and another that causes damaging inflammation – has long been a scientific mystery. This research, published in Cell Reports, sheds light on the molecular switch controlling these divergent pathways, potentially revolutionizing how we approach vascular diseases. The findings could have significant implications for treating conditions where vascular inflammation and leakage are central problems.
The study reveals that the enzyme GRK5 is central to PAR1’s dual function. Interestingly, it’s not whether GRK5 is involved, but where it’s located within the cell that determines the outcome. When GRK5 is anchored to the cell’s plasma membrane, it triggers a protective response. However, when acting within the cytoplasm, it initiates an inflammatory cascade. This nuanced control was previously unknown.
“Our findings provide a detailed molecular explanation for how PAR1 can send such dramatically different messages depending on the activating enzyme,” explained JoAnn Trejo, PhD, corresponding author and professor of pharmacology at UC San Diego School of Medicine. The research team utilized advanced modeling techniques, including the Nobel-prize winning artificial intelligence (AI) tool AlphaFold 3, to understand how different “cuts” to the exterior of PAR1 dictate its behavior inside the cell. This allowed them to visualize the molecular interactions driving these opposing responses.
Unlocking PAR1’s Potential for Therapeutic Intervention
For years, scientists have known that PAR1 is involved in a variety of physiological processes, but the precise mechanisms governing its dual role remained elusive. The UC San Diego team’s function clarifies how PAR1 orchestrates both pro-inflammatory and protective responses, providing crucial insights into the complex interplay of molecular signaling pathways that impact vascular health. The ability to selectively activate the protective arm of PAR1 signaling could be a game-changer in treating a variety of conditions.
Irina Kufareva, PhD, co-corresponding author and professor at the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, added, “This opens the door to therapies that could harness the protective response of PAR1 without potentially triggering the opposite response.” This targeted approach could minimize unwanted side effects often associated with broader anti-inflammatory treatments.
How GRK5 Location Dictates Cellular Response
The research team’s investigation pinpointed the critical role of GRK5, an intermediate enzyme, in mediating PAR1’s effects. GRK5’s location – either anchored to the plasma membrane or acting within the cytoplasm – determines whether the resulting signal is protective or inflammatory. The use of AlphaFold 3 was instrumental in visualizing how different modifications to PAR1 influence GRK5’s activity and, the cellular response. This AI-powered modeling provided a level of detail previously unattainable.
The study, detailed in the March 11, 2026 issue of Cell Reports, offers a new framework for understanding vascular inflammation and identifying potential therapeutic targets. The research builds on previous work demonstrating PAR1’s involvement in conditions like sepsis, heart attack, and stroke, but provides a mechanistic understanding of its complex behavior.
Looking ahead, researchers will focus on developing targeted therapies that can selectively activate the protective functions of PAR1. Further investigation is needed to fully understand the long-term effects of manipulating PAR1 signaling and to identify potential biomarkers that can predict individual responses to treatment. The team is also exploring how these findings might apply to other tissues and organs beyond the vascular system.
This research represents a significant step forward in our understanding of vascular biology and offers a promising avenue for developing new treatments for a wide range of inflammatory diseases. Share your thoughts and questions in the comments below.
Disclaimer: This article is for informational purposes only and should not be considered medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
